Einat Galamidi Cohen

Title: Einat Galamidi Cohen: Innovator in Umbilical Cord Cell Technology

Introduction

Einat Galamidi Cohen is a prominent inventor based in Modiin, Israel. She has made significant contributions to the field of medical technology, particularly in the area of umbilical cord cell transplantation. Her innovative work has the potential to improve treatment options for patients with hematological malignancies.

Latest Patents

Einat holds a patent for her invention titled "Selection and use of umbilical cord cell fractions suitable for transplantation." This patent outlines methods for selecting umbilical cord blood units for ex-vivo expansion. It includes the separation of CD133+/CD34+ positive and uncultured CD133+/CD34- negative fractions. The patent also details methods for expanding the selected CD133+/CD34+ fraction and selecting expanded populations of these cord blood cells for transplantation. Furthermore, it envisions the therapeutic use of both expanded and unselected cord blood fractions in clinical settings.

Career Highlights

Einat is currently associated with Gamida Cell Ltd., where she continues to advance her research and development efforts. Her work is crucial in the ongoing quest to enhance the efficacy of umbilical cord blood therapies.

Collaborations

Einat collaborates with notable colleagues, including Tony Peled and David Snyder, who contribute to her research initiatives and help drive innovation in the field.

Conclusion

Einat Galamidi Cohen's contributions to umbilical cord cell technology exemplify her dedication to improving medical treatments. Her innovative patent and ongoing work at Gamida Cell Ltd. highlight her role as a leading inventor in this vital area of healthcare.